Intermountain Health is the first in the nation to use a new tool using a 3D computer model for rectal cancer surgery. The new technology, called Iris, guides surgeons during robotic rectal cancer ...

Colorectal Surgeon Dr. Julio Garcia-Aguilar, MD, PhD (seated) with nurse Kieran Kelleher BSN-RN. Dr. Garcia-Aguilar and the colorectal service at MSK are experts at the watch and wait approach to ...

Robotic APR shows better short-term outcomes than laparoscopic APR, with lower positive resection margins and conversion rates to open surgery. Robotic APR is associated with longer operation times ...

A new treatment for locally advanced rectal cancer shows favorable results in that surgery can sometimes be avoided completely. It also reduces the risk of recurrence. The method has been confirmed as ...

Non-operative management achieved 95% distant relapse-free survival at 30 months in patients with stage II-III rectal cancer showing a clinical complete response to total neoadjuvant therapy, while ...

Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required. To avoid life-altering ...

Real-world (RW) treatment patterns and clinical outcomes of patients treated with sequential regorafenib and trifluridine/tipiracil ± bevacizumab (BEV) for metastatic colorectal cancer (mCRC) in the ...

Some rectal cancer patients might be spared surgery and the lifelong need for a colostomy bag if they undergo MRI screening, a new study finds. The scans might accurately predict which patients have a ...

New data indicate that nonoperative surveillance after removing a malignant colorectal polyp can achieve high rates of rectal and sphincter preservation without compromising outcomes.

Stage 3 colorectal cancer patients with MRD benefit from Celebrex addition to chemotherapy, showing a 40% risk reduction in death for Signatera-positive patients. Celebrex improved disease-free and ...